AVNS — Avanos Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Avanos Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	715	745	684	673	688
Cost of Revenue
Gross Profit	373	364	394	380	381
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	761	736	650	669	1,084
Operating Profit	-46.1	8.9	34.4	4.2	-396
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-60.5	5.8	26.7	-7.9	-403
Provision for Income Taxes
Net Income After Taxes	-27.2	5.2	21.5	-9.9	-386
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-27.2	5.2	50.5	-61.8	-392
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-27.2	5.2	50.5	-61.8	-392
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.69	1.05	0.713	0.502	-1.92